The USP8 mutational status may predict long-term remission in patients with Cushing's disease.
Adriana AlbaniLuis G Pérez-RivasChristina DimopoulouStephanie ZoppPaula Colón-BoleaSigrun RoeberJürgen HoneggerJörg FlitschWalter RachingerMichael BuchfelderGünter K StallaJochen HermsMartin ReinckeMarily TheodoropoulouPublished in: Clinical endocrinology (2018)
Recurrence appears to be more frequent and earlier after TSS in patients with USP8 mutant corticotroph tumours.